Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin [Articles] - Gu, H., Dutreix, C., Rebello, S., Ouatas, T., Wang, L., Chun, D. Y., Einolf, H. J., He, H. (The American Society for Pharmacology and Experimental Therapeutics (ASPET), 2018)
6137003